haloperidol has been researched along with Wolff-Parkinson-White Syndrome in 2 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The paper reports on a rare case of fulminant neuroleptic malignant syndrome (NMS) with several risk factors, typical manifestation and rapid death induced by low doses of haloperidol." | 7.80 | Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. ( Chen, Y; Huang, P; Li, Z; Liu, N; Qin, Z; Shao, Y; Zhang, J; Zou, D, 2014) |
| "The paper reports on a rare case of fulminant neuroleptic malignant syndrome (NMS) with several risk factors, typical manifestation and rapid death induced by low doses of haloperidol." | 3.80 | Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. ( Chen, Y; Huang, P; Li, Z; Liu, N; Qin, Z; Shao, Y; Zhang, J; Zou, D, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zou, D | 1 |
| Shao, Y | 1 |
| Qin, Z | 1 |
| Zhang, J | 1 |
| Liu, N | 1 |
| Li, Z | 1 |
| Huang, P | 1 |
| Chen, Y | 1 |
| Worley, SJ | 1 |
| Ideker, RE | 1 |
| Mastrototaro, J | 1 |
| Smith, WM | 1 |
| Vidaillet, H | 1 |
| Chen, PS | 1 |
| Lowe, JE | 1 |
2 other studies available for haloperidol and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
Topics: Adult; Antipsychotic Agents; Creatinine; Dose-Response Relationship, Drug; Haloperidol; Humans; Leuk | 2014 |
A new sock electrode for recording epicardial activation from the human heart: one size fits all.
Topics: Animals; Coronary Disease; Dogs; Electrocardiography; Electrodes; Electrophysiology; Epoxy Resins; H | 1987 |